CDT EQUITY INC (CDT) Stock Price, Forecast & Analysis

NASDAQ:CDT • US20678X4034

1.04 USD
-0.06 (-5.45%)
At close: Feb 12, 2026
1.02 USD
-0.02 (-1.92%)
After Hours: 2/12/2026, 8:00:02 PM

CDT Key Statistics, Chart & Performance

Key Statistics
Market Cap1.70M
Revenue(TTM)N/A
Net Income(TTM)-20.70M
Shares1.63M
Float1.38M
52 Week High199.2
52 Week Low0.91
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-473.65
PEN/A
Fwd PEN/A
Earnings (Next)03-23
IPO2022-02-03
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
CDT short term performance overview.The bars show the price performance of CDT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60 -80

CDT long term performance overview.The bars show the price performance of CDT in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of CDT is 1.04 USD. In the past month the price decreased by -25.71%. In the past year, price decreased by -99.47%.

CDT EQUITY INC / CDT Daily stock chart

CDT Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
CDT Full Technical Analysis Report

CDT Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to CDT. CDT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
CDT Full Fundamental Analysis Report

CDT Financial Highlights

Over the last trailing twelve months CDT reported a non-GAAP Earnings per Share(EPS) of -473.65. The EPS increased by 47.46% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -242.03%
ROE -483.82%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%98.52%
Sales Q2Q%N/A
EPS 1Y (TTM)47.46%
Revenue 1Y (TTM)N/A
CDT financials

CDT Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
CDT Analyst EstimatesCDT Analyst Ratings

CDT Ownership

Ownership
Inst Owners1.23%
Ins Owners13.24%
Short Float %4.96%
Short Ratio0.21
CDT Ownership

CDT Latest News, Press Relases and Analysis

All CDT news

CDT Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
TMO THERMO FISHER SCIENTIFIC INC20.54198.063B
DHR DANAHER CORP25.31155.383B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28134.0149.722B
A AGILENT TECHNOLOGIES INC20.6336.543B
IQV IQVIA HOLDINGS INC12.9130.05B
MTD METTLER-TOLEDO INTERNATIONAL29.3728.313B
WAT WATERS CORP22.1119.597B
ILMN ILLUMINA INC22.117.783B
WST WEST PHARMACEUTICAL SERVICES31.0417.709B
MEDP MEDPACE HOLDINGS INC24.7511.942B

About CDT

Company Profile

CDT logo image CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company is headquartered in Naples Florida, Florida and currently employs 6 full-time employees. The company went IPO on 2022-02-03. Through advanced co-crystallization and solidform technologies developed at its Cambridge facility, it is engaged in improving drug properties and has helped in extending the patent life of certain drugs by up to 20 years. Its pipeline includes candidates targeting inflammatory and autoimmune disorders, as well as idiopathic male infertility, dermatology and animal health. The company applies proprietary algorithms utilizing AI-powered disease mapping to identify novel repurposing opportunities against a database of over 800 disease signatures. In addition, the Company has initiated pre-clinical in-vitro models to explore new indications, guided by AI-insights without human intervention.

Company Info

CDT EQUITY INC

4851 Tamiami Trail North, Suite 200

Naples Florida FLORIDA US

Employees: 6

CDT Company Website

CDT Investor Relations

Phone: 13026587581

CDT EQUITY INC / CDT FAQ

What does CDT do?

CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company is headquartered in Naples Florida, Florida and currently employs 6 full-time employees. The company went IPO on 2022-02-03. Through advanced co-crystallization and solidform technologies developed at its Cambridge facility, it is engaged in improving drug properties and has helped in extending the patent life of certain drugs by up to 20 years. Its pipeline includes candidates targeting inflammatory and autoimmune disorders, as well as idiopathic male infertility, dermatology and animal health. The company applies proprietary algorithms utilizing AI-powered disease mapping to identify novel repurposing opportunities against a database of over 800 disease signatures. In addition, the Company has initiated pre-clinical in-vitro models to explore new indications, guided by AI-insights without human intervention.


What is the current price of CDT stock?

The current stock price of CDT is 1.04 USD. The price decreased by -5.45% in the last trading session.


Does CDT EQUITY INC pay dividends?

CDT does not pay a dividend.


What is the ChartMill technical and fundamental rating of CDT stock?

CDT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


What is the Price/Earnings (PE) ratio of CDT EQUITY INC (CDT)?

CDT EQUITY INC (CDT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-473.65).


How many employees does CDT EQUITY INC have?

CDT EQUITY INC (CDT) currently has 6 employees.